IP Library Assignment 046223/0457
Patent Assignment
Reel/Frame 046223/0457

Change of Address

Recorded: 2018-05-23 Pages: 3
Assignor
MEREO BIOPHARMA 1 LIMITED
Executed: 2017-01-01
Assignee
MEREO BIOPHARMA 1 LIMITED
1 CAVENDISH PLACE, 4TH FLOOR, LONDON, W1G 0QF, UNITED KINGDOM
Covered Properties (5)
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Patent: 7,863,314 →
Application: 10/877,534 →
Publication: US 2005/0049288
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Patent: 8,242,117 →
Application: 12/950,649 →
Publication: US 2011/0071152
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Patent: 8,410,160 →
Application: 13/530,919 →
Publication: US 2012/0264801
5-Membered Heterocycle-Based P38 Kinase Inhibitors
Patent: 8,580,838 →
Application: 13/775,963 →
Publication: US 2013/0172352
Use of a Pyrazole Derivative in the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Patent: 9,339,491 →
Application: 14/386,174 →
Publication: US 2015/0031736
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Security Interest Aug 10, 2017
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 043523/0317 →
Security Interest Nov 7, 2018
From: MEREO BIOPHARMA 1 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0556 →
Release of Security Interest Jan 23, 2021
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMINTED
Reel/Frame 055010/0654 →
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 55010 Frame: 654. Assignor(S) Hereby Confirms the Release of Security Interest . Oct 29, 2024
From: KREOS CAPITAL V (UK) LIMITED
To: MEREP BIOPHARMA 1 LIMITED
Reel/Frame 069273/0237 →
Corrective Assignment to Correct the Spelling of the Receiving Party Data from Merep Biopharma I Limited to Mereo Biopharma 1 Limited Previously Recorded on Reel 69273 Frame 237. Assignor(S) Hereby Confirms the Corrective Assignment. Apr 10, 2025
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 1 LIMITED
Reel/Frame 070808/0578 →